Opportunity overview
Project title: NHS National Framework for Lenvatinib Offer reference number: CM/TNS/26/5751 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. CM/TNS/26/5751 Lenvatinib Lot 1 CESW: 01/06/2027 to 31/01/2029 (20 months) Lot 2 NWLN: 01/06/2027 to 30/09/2028 (16 months) Lot 3 LSNE: 01/06/2027 to 31/05/2028 (12 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Classification
- CPV33600000 — Pharmaceutical products
Lots
- Lot 1£35.8m
Documents and notices
- Tender notice on Find a TenderOpen source ↗
- Document No. 01 - Invitation to offer covering letter - CM-TNS-26-5751Open source ↗
- Document No. 02 - Terms of offer - CM-TNS-26-5751Open source ↗
- Document No. 03 - Framework Agreement and Terms and Conditions - CM-TNS-26-5751Open source ↗
- Document No. 04 - Quality Assurance Process - CM-TNS-26-5751Open source ↗
- Document No. 05 - Selectt offer schedule instructions - CM-TNS-26-5751Open source ↗
- Document No. 05a Selectt offer schedule - CM_TNS_26_5751_01Open source ↗
- Document No. 05b Tender Product Listing and Usage - CM-TNS-26-5751Open source ↗
- Document No. 06 - Form of offer - CM-TNS-26-5751Open source ↗
- Document No. 07 - Quality control technical sheet - CM-TNS-26-5751Open source ↗
- Document No. 08 - Confidential information schedule - CM-TNS-26-5751Open source ↗
- Document No. 09 - Pharmacy Purchasing Points List - CM-TNS-26-5751Open source ↗
- Document No. 10 - Requirement Section 1. Procurement Specific Questionnaire (PSQ) - CM-TNS-26-5751Open source ↗